SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParkmead Regulatory News (PMG)

Share Price Information for Parkmead (PMG)

Share Price is delayed by 15 minutes
Get Live Data
18.75    -1.00 (-5.06%)
Bid:
18.00
Ask:
19.50
Spread: 1.50 (8.333%)
Market Cap: £20.49m
PMG Live PriceLast checked at - London Stock Exchange

Intraday Parkmead Share Chart

Director shareholding

23 May 2006 07:03

Parkmead Group (The) PLC23 May 2006 The Parkmead Group PLC Director shareholding and issue of options Following the recent changes to the company structure, combined with thesuccessful fund raising and acquisition of Quayside Corporate Services, theBoard of The Parkmead Group has agreed to introduce share-based incentiveschemes for its key executive directors. To this effect, the Board is todayannouncing the following in respect of Niall Doran, Chief Executive of TheParkmead Group: Firstly, an Employee Benefit Trust (EBT) is being established which willsubscribe for 33,485,616 new ordinary 5p shares at a price of 8 pence per share(the current market price is 7.75p). This is equivalent to 10% of the currentoutstanding issued share capital of The Parkmead Group. The EBT willsubsequently make a loan to Mr Doran to purchase these shares from the EBTitself and he will become beneficial owner of the shares. As a result, thenumber of shares in issue will increase to 368,335,112. Secondly, Mr Doran is being granted options over a further 33,485,616 shares,with an exercise price of 8 pence. Half of these may be exercised if the shareprice of The Parkmead Group trades at or above 18 pence and the other halfsimilarly at a price of 27 pence. The options have a ten-year lifespan and willlapse if not exercised in that period. The number of shares currently under option is 29,537,423 and the issue of theabove options would therefore bring the total to 63,023,039 or 17.1% of theincreased shares in issue, pursuant to the EBT transaction. In defining the above amounts the Board has been mindful of both the ABIguidelines in respect of the recommended amount of options which may beavailable at any time as well as the need to set demanding targets for theoptions to crystallise. In setting the levels of share price threshold at 125%and 237.5% respectively above the exercise price, the Board considers that theinterests of executives and investors are fully aligned. The Board has consultedwith its major institutional shareholders, all of whom have indicated theirsupport for the recommendations above. Ends Enquiries: Madano Partnership (PR to The Parkmead Group) Matthew Moth/Toby Wilkinson 0207 593 4000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Mar 20267:00 amRNSInterim Results for Six Months Ended 31 Dec 2025
23rd Dec 20251:00 pmRNSResult of AGM
23rd Dec 20251:00 pmRNSResult of AGM
25th Nov 20257:00 amRNSPreliminary Results Statement 2025
14th Nov 20257:00 amRNSBoard Appointment
1st Aug 20257:00 amRNSExtension of Loan
22nd Jul 20257:00 amRNSOperational Update
30th May 20253:32 pmRNSHolding(s) in Company
1st May 20257:00 amRNSCompletion of the sale of Parkmead (E&P) Ltd
28th Mar 20257:00 amRNSInterim Results for Six Months Ended 31 Dec 2024
23rd Dec 202411:15 amRNSResult of AGM
12th Dec 20247:01 amRNSSale of Parkmead (E&P) Ltd
26th Nov 20247:00 amRNSPreliminary Results Statement 2024
30th Jul 20247:00 amRNSExtension of Loan
19th Jul 202410:36 amRNSFormal Award of UK Licence P2634
28th Mar 20247:00 amRNSInterim Results for Six Months Ended 31 Dec 2023
5th Feb 20247:00 amRNSProvisional Award of Three New UK Offshore Blocks
2nd Feb 20247:00 amRNSUpdate on Netherlands and Renewables Portfolios
21st Dec 202312:30 pmRNSResult of AGM
17th Nov 20237:00 amRNSPreliminary Results Statement 2023
3rd Nov 20235:15 pmRNSNotice of Results and Trading Update
19th Jun 20231:20 pmRNSUK North Sea Strategy Update
15th Jun 20237:00 amRNSBoard Strategy and Development
30th May 20238:15 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSStrong Progress Across Netherlands Assets
6th Apr 20237:00 amRNSNew gas discovery comes onstream
5th Apr 20237:00 amRNSHolding(s) in Company
31st Mar 20237:00 amRNSInterim Results for six-months ended 31 Dec 2022
12th Jan 20237:00 amRNSNew Gas Discovery in the Netherlands
21st Dec 20221:50 pmRNSResult of AGM
23rd Nov 20227:01 amRNSNotice of AGM
23rd Nov 20227:00 amRNSPreliminary Results Statement 2022
16th Nov 20227:00 amRNSTwo-well Drilling Campaign in the Netherlands
6th Oct 20227:00 amRNSUpdate on Renewable Energy Projects
15th Sep 20227:00 amRNSUpdate on Skerryvore
29th Jul 20227:00 amRNSLaunch of Greater Perth Area farm-out
6th Jul 20227:00 amRNSRecord Gas Revenues and Accelerated New Drilling
25th Mar 20227:00 amRNSInterim Results for six-months ended 31 Dec 2021
1st Feb 20227:00 amRNSWind Power Acquisition
24th Jan 20224:41 pmRNSSecond Price Monitoring Extn
24th Jan 20224:37 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:36 pmRNSPrice Monitoring Extension
22nd Dec 202111:35 amRNSResult of AGM
26th Nov 20214:00 pmRNSNotice of AGM
26th Nov 20217:00 amRNSPreliminary Results Statement 2021
12th Oct 20214:41 pmRNSSecond Price Monitoring Extn
12th Oct 20214:35 pmRNSPrice Monitoring Extension
26th Aug 20214:35 pmRNSPrice Monitoring Extension
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.